S. Bui

2.4k total citations
70 papers, 989 citations indexed

About

S. Bui is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Emergency Medical Services. According to data from OpenAlex, S. Bui has authored 70 papers receiving a total of 989 indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Pulmonary and Respiratory Medicine, 15 papers in Epidemiology and 13 papers in Emergency Medical Services. Recurrent topics in S. Bui's work include Cystic Fibrosis Research Advances (50 papers), Neonatal Respiratory Health Research (17 papers) and Tracheal and airway disorders (14 papers). S. Bui is often cited by papers focused on Cystic Fibrosis Research Advances (50 papers), Neonatal Respiratory Health Research (17 papers) and Tracheal and airway disorders (14 papers). S. Bui collaborates with scholars based in France, United States and Germany. S. Bui's co-authors include Ute Hochgeschwender, Michaël Fayon, Miles B. Brennan, Stacy Forbes, Julie Macey, Gaël Dournes, Patrick Berger, Raphaël Enaud, François Laurent and Laurence Delhaès and has published in prestigious journals such as Proceedings of the National Academy of Sciences, American Journal of Respiratory and Critical Care Medicine and Radiology.

In The Last Decade

S. Bui

64 papers receiving 972 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Bui France 17 522 159 154 127 125 70 989
Dominique Singer Germany 17 329 0.6× 149 0.9× 130 0.8× 111 0.9× 103 0.8× 99 1.1k
D. E. Niewoehner United States 20 781 1.5× 112 0.7× 402 2.6× 146 1.1× 173 1.4× 36 1.2k
Paul W. Francis Australia 14 740 1.4× 57 0.4× 232 1.5× 112 0.9× 61 0.5× 25 982
Hilde Franckx Belgium 16 280 0.5× 119 0.7× 198 1.3× 48 0.4× 130 1.0× 23 652
Tom Hilliard United Kingdom 20 859 1.6× 85 0.5× 369 2.4× 449 3.5× 143 1.1× 46 1.4k
Joanne Harrison Australia 14 185 0.4× 167 1.1× 113 0.7× 99 0.8× 73 0.6× 42 679
Emmanouil Paraskakis Greece 19 512 1.0× 71 0.4× 595 3.9× 52 0.4× 78 0.6× 59 1.0k
M. Mostert Italy 17 160 0.3× 41 0.3× 95 0.6× 143 1.1× 150 1.2× 64 1.1k
Kirsti Heinonen Finland 20 643 1.2× 119 0.7× 131 0.9× 358 2.8× 68 0.5× 48 1.6k
Yung‐Che Chen Taiwan 21 451 0.9× 157 1.0× 319 2.1× 209 1.6× 277 2.2× 78 1.2k

Countries citing papers authored by S. Bui

Since Specialization
Citations

This map shows the geographic impact of S. Bui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Bui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Bui more than expected).

Fields of papers citing papers by S. Bui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Bui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Bui. The network helps show where S. Bui may publish in the future.

Co-authorship network of co-authors of S. Bui

This figure shows the co-authorship network connecting the top 25 collaborators of S. Bui. A scholar is included among the top collaborators of S. Bui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Bui. S. Bui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Benaboud, Sihem, Laurent Chouchana, Sophie Gautier, et al.. (2025). WS02.06Elexacaftor/tezacaftor/ivacaftor pharmacokinetics and occurrence of behavioural disorders in children aged 2 to 5 years old. Journal of Cystic Fibrosis. 24. S5–S5.
2.
Beaufils, Fabien, Raphaël Enaud, Julie Macey, et al.. (2023). Adherence, reliability, and variability of home spirometry telemonitoring in cystic fibrosis. Frontiers in Pediatrics. 11. 1111088–1111088. 14 indexed citations
3.
Gilchrist, Francis, S. Bui, Silvia Gärtner, et al.. (2023). ALPINE2: Efficacy and safety of 14-day vs 28-day inhaled aztreonam for Pa eradication in children with cystic fibrosis. Journal of Cystic Fibrosis. 23(1). 80–86. 2 indexed citations
4.
Mathieu, David, Ilyès Benlala, S. Bui, et al.. (2023). Longitudinal Evaluation of Bronchial Changes in Cystic Fibrosis Patients Undergoing Elexacaftor/Tezacaftor/Ivacaftor Therapy Using Lung MRI With Ultrashort Echo‐Times. Journal of Magnetic Resonance Imaging. 60(1). 116–124. 9 indexed citations
5.
Benlala, Ilyès, Julie Macey, S. Bui, et al.. (2023). Non‐Contrast‐Enhanced Functional Lung MRI to Evaluate Treatment Response of Allergic Bronchopulmonary Aspergillosis in Patients With Cystic Fibrosis: A Pilot Study. Journal of Magnetic Resonance Imaging. 59(3). 909–919. 2 indexed citations
6.
Benlala, Ilyès, Baudouin Denis de Senneville, Thomas Benkert, et al.. (2023). Generating High-Resolution Synthetic CT from Lung MRI with Ultrashort Echo Times: Initial Evaluation in Cystic Fibrosis. Radiology. 308(1). e230052–e230052. 10 indexed citations
7.
Enaud, Raphaël, Éric Frison, Victor de Lédinghen, et al.. (2021). Cystic fibrosis and noninvasive liver fibrosis assessment methods in children. Pediatric Research. 91(1). 223–229. 6 indexed citations
8.
Enaud, Raphaël, Katarzyna B. Hooks, Aurélien Barré, et al.. (2019). Intestinal Inflammation in Children with Cystic Fibrosis Is Associated with Crohn’s-Like Microbiota Disturbances. Journal of Clinical Medicine. 8(5). 645–645. 53 indexed citations
9.
Burgel, Pierre‐Régis, À. Munck, I. Durieu, et al.. (2019). Real-Life Safety and Effectiveness of Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 201(2). 188–197. 92 indexed citations
10.
Macey, Julie, S. Bui, Michaël Fayon, et al.. (2019). CT evaluation of hyperattenuating mucus to diagnose allergic bronchopulmonary aspergillosis in the special condition of cystic fibrosis. Journal of Cystic Fibrosis. 18(4). e31–e36. 14 indexed citations
11.
Bui, S., Stéphanie Leroux, Fabienne Nacka, et al.. (2018). Variability of ciprofloxacin pharmacokinetics in children: impact on dose range in sickle cell patients. Journal of Antimicrobial Chemotherapy. 73(12). 3423–3429. 6 indexed citations
12.
El-Rabbany, Mohamed, et al.. (2017). A Quality Analysis of Systematic Reviews in Dentistry, Part 1: Meta-Analyses of Randomized Controlled Trials. Journal of Evidence Based Dental Practice. 17(4). 389–398. 14 indexed citations
13.
Hubert, D., S. Bui, C. Marguet, et al.. (2016). Nouvelles thérapeutiques de la mucoviscidose ciblant le gène ou la protéine CFTR. Revue des Maladies Respiratoires. 33(8). 658–665. 4 indexed citations
14.
Barthe, Christophe, Subhadra Nandakumar, Julie Macey, et al.. (2015). Exploring the expression of Pseudomonas aeruginosa genes directly from sputa of cystic fibrosis patients. Letters in Applied Microbiology. 61(5). 423–428. 2 indexed citations
15.
Reix, Philippe, et al.. (2013). Which BAL fluid (BALF) analyses are clinically useful in immunocomptent children?. European Respiratory Journal. 42(Suppl 57). P1243–P1243. 1 indexed citations
16.
Fayon, Michaël, Harriet Corvol, R. Chiron, et al.. (2013). Consensus national sur les modalités de prescription des corticoïdes inhalés dans la mucoviscidose. Archives de Pédiatrie. 21(1). 88–94. 2 indexed citations
17.
Bui, S., et al.. (2012). L'inflammation pulmonaire dans la mucoviscidose. Archives de Pédiatrie. 19. S8–S12. 4 indexed citations
18.
Harambat, Jérôme, S. Bui, Fabienne Nacka, et al.. (2010). Renal impairment in children with cystic fibrosis. Journal of Cystic Fibrosis. 9(4). 263–268. 12 indexed citations
19.
Bui, S., et al.. (2009). Intravenous peripherally-inserted central catheters for antibiotic therapy in children with cystic fibrosis. Journal of Cystic Fibrosis. 8(5). 326–331. 15 indexed citations
20.
Bui, S., et al.. (2005). Formes atypiques ou rares de la mucoviscidose. MTP. Médecine thérapeutique pédiatrie. 8(3). 225–229. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dominique Singer Breakdown of academic impact, for papers by D. E. Niewoehner Breakdown of academic impact, for papers by Paul W. Francis Breakdown of academic impact, for papers by Hilde Franckx Breakdown of academic impact, for papers by Tom Hilliard Breakdown of academic impact, for papers by Joanne Harrison Breakdown of academic impact, for papers by Emmanouil Paraskakis Breakdown of academic impact, for papers by M. Mostert Breakdown of academic impact, for papers by Kirsti Heinonen Breakdown of academic impact, for papers by Yung‐Che Chen
Rankless by CCL
2026